Cresset Asset Management’s Fate Therapeutics FATE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-6,200
Closed -$510K 1037
2021
Q1
$510K Buy
+6,200
New +$510K 0.01% 474